Intriguingly, lenalidomide-sensitive MDS/AML cell lines, including MDSL, KG-1α and F36P, exhibit increased expression of calpain 1 (CAPN1) protein in the presence of lenalidomide that is independent of IKZF1 or GPR68. The gene discussed is CAPN1; the disease is acute myeloid leukemia.